Non-profit disease foundation the Leukemia and Lymphoma Society and drug-discovery startup Forma Therapeutics this week announced a partnership to accelerate the development of therapeutic research projects in LLS' pipeline.
Under the collaboration, LLS will select ten small molecule candidates deemed to have the best chance of quickly advancing to clinical trials from its portfolio of grant-funded academic research projects.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
